CUE CUE BIOPHARMA INC
FollowCOM (common), issuer CIK 1645460
48 managers (50 13F filers) reported a position in CUE shares at 2026-06-30, 1,655,527 shares in all. 49 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 48
- 13F filers
- 50
- New
- 49
- Added
- 0
- Reduced
- 1
- Sold out
- 1
- Shares held by filers
- 1,655,527
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Driehaus Capital Management LLC
292,144 shares, 4.02% in a 13G/A as of 2026-09-30,0000938206-26-000052
Accepted , ingested - Balyasny Asset Management L.P.(group Balyasny Asset Management)
427,231 shares, 5.88% in a 13G as of 2026-09-30,0001172661-26-005042
Accepted , ingested - Cormorant Asset Management, LP(group Cormorant Asset Management, LP)
791,377 shares, 9.99% in a 13G as of 2026-09-30,0001172661-26-005293
Accepted , ingested - STROME MARK E (group STROME MARK E)
644,916 shares, 8.5% in a 13G/A as of 2026-07-14,0001213900-26-107721
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Ray Sumitaofficer (Chief Legal Compliance Officer), other | 2026-10-12 | -1,844 S | $28.05 | Form 4 |
| Meluzio Michael Vincentofficer (VP, Prin. Accounting Officer) | 2026-10-12 | -1,144 S | $28.05 | Form 4 |
| Lin Shao-Leedirector, officer (Chief Executive Officer) | 2026-10-12 | -1,087 S | $28.05 | Form 4 |
| Lin Shao-Leedirector, officer (Chief Executive Officer) | 2026-10-12 | -10,000 S | $27.5 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Cormorant Asset Management, LP and 1 other reporting person reported 791,377 CUE shares, 9.99% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001172661-26-005293
Accepted , ingestedDriehaus Capital Management LLC reported 292,144 CUE shares, 4.02% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0000938206-26-000052
Accepted , ingestedBalyasny Asset Management L.P. and 4 other reporting persons reported 427,231 CUE shares, 5.88% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001172661-26-005042
Accepted , ingestedRay Sumita sold 1,844 CUE shares on 2026-10-12, Form 4 filed 2026-10-14. 0001579629-26-000012
Accepted , ingestedMeluzio Michael Vincent sold 1,144 CUE shares on 2026-10-12, Form 4 filed 2026-10-14. 0002138368-26-000009
Accepted , ingestedLin Shao-Lee sold 11,087 CUE shares on 2026-10-12, Form 4 filed 2026-10-14. 0001725092-26-000019
Accepted , ingestedSTROME MARK E and 5 other reporting persons reported 644,916 CUE shares, 8.5% of the class, as of 2026-07-14, in a 13G/A filed 2026-10-08. 0001213900-26-107721
Accepted , ingested